Triasima Portfolio Management Inc. Charles River Laboratories International, Inc. Transaction History

Triasima Portfolio Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jul 20, 2022	SELL	$255.51 - $362.11 $198,020 - $280,635	-775 Closed	0 $0
Q4 2021 Mar 10, 2023	SELL	$351.38 - $448.68 $2.21 Million - $2.82 Million	-6,295 Reduced 89.04%	775 $292,000
Q4 2021 Jul 20, 2022	SELL	$351.38 - $448.68 $2.21 Million - $2.82 Million	-6,295 Reduced 89.04%	775 $292,000
Q3 2021 Mar 10, 2023	BUY	$372.64 - $458.3 $2.04 Million - $2.51 Million	5,485 Added 346.06%	7,070 $2.92 Million
Q3 2021 Jul 20, 2022	BUY	$372.64 - $458.3 $2.04 Million - $2.51 Million	5,485 Added 346.06%	7,070 $2.91 Million
Q2 2021 Mar 10, 2023	BUY	$294.17 - $371.65 $255,927 - $323,335	870 Added 121.68%	1,585 $586,000
Q2 2021 Jul 20, 2022	BUY	$294.17 - $371.65 $255,927 - $323,335	870 Added 121.68%	1,585 $586,000
Q1 2021 Mar 10, 2023	BUY	$249.67 - $299.48 $178,514 - $214,128	715 New	715 $207,000
Q4 2020 Jul 20, 2022	BUY	$222.0 - $252.62 $158,730 - $180,623	715 New	715 $179,000

703

52.8M

157K

413K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.73B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

Stay updated on Triasima Portfolio Management Inc. with notifications on news.